Business
Geron to Announce Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2019 financial
About this update from Geron Corporation
[{"type":"text","content":" MENLO PARK, Calif.--(BUSINESS WIRE)--\nGeron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2019 financial results after the market closes on Thursday, March 12, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results and 2020 milestones at 4:30 p.m. ET the same day.\n\n\nParticipants may access the conference call live via telephone by dialing domestically +1 (866) 393-4306 or internationally +1 (734) 385-2616. The passcode is 5528886. Participants are advised to dial in at least 10 minutes prior to minimize any delay in joining the call. A live, listen-only webcast will also be available on the Company’s website at www.geron.com/investors/events. If you are unable to listen to the live call, an archived webcast will be available on the Company’s website for 30 days.\n\n\nAbout Geron\n\n\nGeron is a clinical late-stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200305005850/en/\n\nSuzanne Messere\nInvestor and Media Relations\[email protected]\[email protected]\n\n\nCG Capital\n877-889-1972\n\nSource: Geron Corporation","length":3129,"tagName":"div"}]